Apollomics appoints matthew plunkett, ph.d. as chief financial officer

Foster city, calif., march 04, 2024 (globe newswire) -- apollomics inc. (“apollomics” or the “company”), a clinical-stage biopharmaceutical company developing medicines to address difficult-to-treat cancers, today announced that matthew plunkett, ph.d., has been appointed as chief financial officer of apollomics.
APLM Ratings Summary
APLM Quant Ranking